Do You Qualify for Enhertu Coverage by UnitedHealthcare in Washington? Decision Tree & Next Steps
Answer Box
UnitedHealthcare requires prior authorization (PA) for Enhertu (fam-trastuzumab deruxtecan-nxki) in Washington, mandating HER2-positive biomarker testing, specific cancer diagnoses, and evidence of prior HER2-targeted therapy failure. Submit PA via the UnitedHealthcare Provider Portal with pathology reports, treatment history, and oncologist letter. If denied, Washington residents can appeal internally (60